These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 10383133)
21. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications. Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma. Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454 [TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas. Fietkau R; Iro H; Tulusan AH; Dressel V; Altendorf-Hofmann A; Sauer R Strahlenther Onkol; 1994 Jan; 170(1):13-24. PubMed ID: 8303573 [TBL] [Abstract][Full Text] [Related]
25. Expression of protein tyrosine kinases in head and neck squamous cell carcinomas. Ongkeko WM; Altuna X; Weisman RA; Wang-Rodriguez J Am J Clin Pathol; 2005 Jul; 124(1):71-6. PubMed ID: 15923166 [TBL] [Abstract][Full Text] [Related]
26. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas. Jang YJ; Kim YS; Kim WH Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274 [TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212 [TBL] [Abstract][Full Text] [Related]
28. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064 [TBL] [Abstract][Full Text] [Related]
30. RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma. Brunner M; Erovic B; Heiduschka G; Schneider S; Pammer J; Frantal S; Thurnher D Eur Surg Res; 2010; 44(3-4):214-9. PubMed ID: 20571277 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma. Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703 [TBL] [Abstract][Full Text] [Related]
32. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296 [TBL] [Abstract][Full Text] [Related]
33. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck. Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocytes. Georgescu SP; Komuro I; Hiroi Y; Mizuno T; Kudoh S; Yamazaki T; Yazaki Y J Mol Cell Cardiol; 1997 Mar; 29(3):929-37. PubMed ID: 9152854 [TBL] [Abstract][Full Text] [Related]
35. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684 [TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas. Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173 [TBL] [Abstract][Full Text] [Related]
39. Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner. Ree AH; Bratland A; Solberg Landsverk K; Fodstad O Anticancer Res; 2004; 24(2B):555-62. PubMed ID: 15160994 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of Pim-1 in head and neck squamous cell carcinomas. Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]